home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences  

Joint DIA/EFGCP Pharmacovigilance Audit and Inspection - Opportunities for Patient Safety

  April 28, 2010  
De Vere Venues , London, UK
Oct 1 2010 7:00AM - 5:00PM

Key Topics
Audit and inspection findings related to:
• Management of individual case safety reports such as assessment of case validity, lack of efficacy, information derived from the Internet
• Record retention and storage, paper versus electronic records
• Pharmacovigilance quality system, structure, documentation, Detailed Description of Pharmacovigilance Systems (DDPS) updates, role of European Qualified
Person for Pharmacovigilance (QPPV)
• Reporting of inspection findings, assessment against internal/external references, interpretation of regulatory requirements, consistency across inspections,
options for dialogue and escalation

Other aspects:
• Targeted versus routine inspections
• Feedback from assessments relevant to pharmacovigilance quality system
• Affiliates inspections in the EU and rest of the world
• Inspections of licensing partner, distributors and vendors
• Best practices on how to prepare, conduct, report a pharmacovigilance inspection – mutual experience and recommendations
• Role of performance metrics in pharmacovigilance quality systems

Target Audience:
Who Will Attend
Professionals from regulatory agencies, industry, non-profit organisations involved in clinical research, drug safety monitoring and related quality management

Event Code:
Organized by: DIA Europe
Invited Speakers: Call contact
Deadline for Abstracts: call contact
Registration: DIA EUROPE


4002 BASEL, SWITZERLANDPHONE: +41 61 225 51 51FAX: +41 61 225 51 52
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.